RT Journal Article
SR Electronic
T1 Modelling the impact of non-pharmaceutical interventions on workplace transmission of SARS-CoV-2 in the home-delivery sector
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.17.22272414
DO 10.1101/2022.03.17.22272414
A1 Whitfield, Carl A.
A1 van Tongeren, Martie
A1 Han, Yang
A1 Wei, Hua
A1 Daniels, Sarah
A1 Regan, Martyn
A1 Denning, David W.
A1 Verma, Arpana
A1 Pellis, Lorenzo
A1 Hall, Ian
A1 the University of Manchester COVID-19 Modelling Group
YR 2023
UL http://medrxiv.org/content/early/2023/03/23/2022.03.17.22272414.abstract
AB Objective We aimed to use mathematical models of SARS-COV-2 to assess the potential efficacy of non-pharmaceutical interventions on transmission in the parcel delivery and logistics sector.Methods We developed a network-based model of workplace contacts based on data and consultations from companies in the parcel delivery and logistics sectors. We used these in stochastic simulations of disease transmission to predict the probability of workplace outbreaks in this settings. Individuals in the model have different viral load trajectories based on SARS-CoV-2 in-host dynamics, which couple to their infectiousness and test positive probability over time, in order to determine the impact of testing and isolation measures.Results The baseline model (without any interventions) showed different workplace infection rates for staff in different job roles. Based on our assumptions of contact patterns in the parcel delivery work setting we found that when a delivery driver was the index case, on average they infect only 0.14 other employees, while for warehouse and office workers this went up to 0.65 and 2.24 respectively. In the LIDD setting this was predicted to be 1.40, 0.98, and 1.34 respectively. Nonetheless, the vast majority of simulations resulted in 0 secondary cases among customers (even without contact-free delivery). Our results showed that a combination of social distancing, office staff working from home, and fixed driver pairings (all interventions carried out by the companies we consulted) reduce the risk of workplace outbreaks by 3-4 times.Conclusion This work suggests that, without interventions, significant transmission could have occured in these workplaces, but that these posed minimal risk to customers. We found that identifying and isolating regular close-contacts of infectious individuals (i.e. house-share, carpools, or delivery pairs) is an efficient measure for stopping workplace outbreaks. Regular testing can make these isolation measures even more effective but also increases the number of staff isolating at one time. It is therefore more efficient to use these isolation measures in addition to social distancing and contact reduction interventions, rather than instead of, as these reduce both transmission and the number of people needing to isolate at one time.Author summary During the COVID-19 pandemic the home-delivery sector was vital to maintaining people’s access to certain goods, and sustaining levels of economic activity for a variety of businesses. However, this important work necessarily involved contact with a large number of customers as well as colleagues. This means that questions have often been raised about whether enough was being done to keep customers and staff safe. Estimating the potential risk to customers and staff is complex, but here we tackle this problem by building a model of workplace and customer contacts, from which we simulate SARS-CoV-2 transmission. By involving industry representatives in the development of this model, we have simulated interventions that have either been applied or considered, and so the findings of this study are relevant to decisions made in that sector. Furthermore, we can learn generic lessons from this specific case study which apply to many types of shared workplace as well as highlighting implications of the highly stochastic nature of disease transmission in small populations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded by the UK Research and Innovation (UKRI) and National Institute for Health Research (NIHR) COVID-19 Rapid Response call, Grant Ref: MC_PC_19083. MvT is the Principal Investigator of the project. CAW and SD held post-doctoral posts funded by this grant. LP is supported by the Wellcome Trust and the Royal Society (grant no. 202562/Z/16/Z). IH is supported by the National Institute for Health Research Policy Research Programme in Operational Research (OPERA, PR-R17-0916-21001). IH and LP are supported by The Alan Turing Institute for Data Science and Artificial Intelligence, EPSRC (EP/V027468/1). CAW, IH, and LP were also supported by UKRI through the JUNIPER modelling consortium (grant no. MR/V038613/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University Research Ethics Committee at University of Manchester gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe minimal required dataset to reproduce the findings in this manuscript are available open access, as follows: All of the simulated data presented in the manuscript can be accessed at https://doi.org/10.48420/22219564 and scripts to reproduce the plots from this data at https://doi.org/10.48420/22226266 . Additionally, the source code used to generate the data can be found at https://github.com/CarlWhitfield/Workplace_delivery_transmission, with input data at https://doi.org/10.48420/22232833. Further information regarding company consultations and their subsequent analysis can be found here https://doi.org/10.3389/fpubh.2022.864506. Full transcripts of these consultations or raw data provided by these companies (which are not requied to reproduce the results in this manuscript) can not be shared due to commercial sensitivity and to preserve the anonymity of participants, as per the data sharing agreements and participation consent forms in place with these participants. https://github.com/CarlWhitfield/Viral_load_testing_COV19_model https://github.com/CarlWhitfield/Workplace_delivery_transmission